The Worldwide Fetal Monitoring Industry is Projected to Reach $5.2 Billion by 2026 at a CAGR of 7.2% from 2021

Research and Markets
·9 min read

Dublin, April 14, 2021 (GLOBE NEWSWIRE) -- The "Fetal Monitoring Market by Product (Ultrasound (3D & 4D), Fetal Electrodes, Telemetry Devices, Accessories and Consumables), Portability (Portable Systems), Method (Invasive), Application (Antepartum), End User (Hospitals) - Global Forecast to 2026" report has been added to ResearchAndMarkets.com's offering.

The global fetal monitoring market is projected to USD 5.2 billion by 2026 from USD 3.7 billion in 2021, at a CAGR of 7.2% from 2021 to 2026.

The growth of this market is driven owing to the escalating prevalence of preterm births, favorable government policies, advanced technologies of fetal monitoring systems, and active product launches. Also, the development of noninvasive, portable, and advanced fetal monitors and emerging markets and strengthening infrastructure are anticipated to offer an opportunity for the growth of the market during the forecast period.

Ultrasound Devices is expected to hold the largest share of the fetal monitoring market, by product in 2021

Based on products, the fetal monitoring market is segmented into ultrasound devices, electronic maternal/fetal monitors, fetal electrodes, fetal doppler devices, uterine contraction monitors, telemetry devices, accessories & consumables, and other products. Ultrasound devices are the largest segment in this market. This segment's growth can primarily be attributed to technological advancements, increasing congenital anomalies, maternal mortality, and rising regulatory approvals.

Non-portable systems are expected to hold the largest share of the fetal monitoring market, by portability in 2021

Based on portability, the market is segmented into non-portable systems and portable systems. In 2020, non-portable systems accounted for the largest share of this market, owing to wide applications in hospitals and diagnostic centers to assess fetal and maternal health.

Noninvasive is expected to hold the largest share of the fetal monitoring market, by method in 2021

Based on the method, the market is segmented into invasive and noninvasive. In 2020, the noninvasive accounted for the largest share of this market. Noninvasive methods are widely accepted for their safer method of diagnosing and monitoring the fetus, especially in high-risk pregnancies. The rising approvals of various noninvasive monitoring devices and the incoming advanced technologies drive the growth of this segment.

Antepartum is expected to hold the largest share of the fetal monitoring market, by application in 2021

Based on application, the market is segmented into antepartum and intrapartum. The antepartum segment accounts for the largest share of the fetal monitoring market. Antepartum fetal monitoring is carried out throughout the gestation period to diagnose any congenital fetal abnormalities. The extensive monitoring regimes, recent product launches, surging prevalence of fetal anomalies, and maternal mortalities drive the growth of the antepartum segment.

Hospitals are expected to hold the largest share of the fetal monitoring market, by end user in 2021

The market is segmented into hospitals, obstetrics & gynecology clinics, and home care settings based on end users. In 2020, hospitals accounted for the largest share of this market. This segment's growth can be attributed to several factors, such as highly advanced facilities in hospitals and the increasing number of pregnancy procedures. Technological advancements, coupled with government funding, are also encouraging the installation of new tools and devices in hospitals, thus supporting market growth.

North America commanded the largest share of the fetal monitoring market in 2021

On the basis of region, the fetal monitoring market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. In 2019, North America commanded the largest share of the fetal monitoring market. The large share of this market segment can be attributed to the presence of an established reimbursement structure coupled with availability of experts in the North American countries.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights
4.1 Fetal Monitoring Market Overview
4.2 North America Fetal Monitoring Market Share, By Portability (2020)
4.3 Geographical Snapshot Of The Fetal Monitoring Market

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 The Rising Number Of Preterm Births And The Increasing Adoption Of Infertility Treatments
5.2.1.2 Advanced And Innovative Fetal Monitoring Technologies
5.2.1.3 Government Initiatives And Increasing Collaborations For Research By Health Agencies
5.2.1.4 Reimbursements And Insurance Policies For Fetal Monitoring Services
5.2.1.5 Active Product Launches By Key Manufacturers
5.2.2 Restraints
5.2.2.1 High Costs Of Fetal Monitoring Equipment
5.2.2.2 Availability Of Refurbished Products
5.2.3 Opportunities
5.2.3.1 Development Of Noninvasive, Portable, And Advanced Fetal Monitors
5.2.3.2 Emerging Markets And Strengthening Infrastructure
5.2.4 Challenges
5.2.4.1 Product Recalls
5.3 Supply Chain Analysis
5.4 Value Chain Analysis
5.5 Ecosystem Analysis
5.5.1 Role In The Ecosystem
5.6 Regulatory Landscape
5.6.1 EU Regulations
5.6.2 US Regulations
5.7 Porter's Five Forces Analysis
5.7.1 Threat From New Entrants
5.7.2 Bargaining Power Of Suppliers
5.7.3 Bargaining Power Of Buyers
5.7.4 Intensity Of Competitive Rivalry
5.7.5 Threat Of Substitutes
5.8 Covid-19 Impact Analysis On The Fetal Monitoring Market
5.9 Patent Analysis
5.9.1 Uterine Contraction Monitors
5.9.2 Fetal Dopplers
5.9.3 Fetal Electrodes
5.10 Trade Analysis (Ultrasound)
5.10.1 Import Data For Ultrasound (Value), By Country, 2017-2019 (USD Million)
5.10.2 Export Data For Ultrasound (Value), By Country, 2017-2019 (USD Million)
5.10.3 Export Data For Ultrasound (Volume), By Country, 2017-2019 (Kilograms)
5.10.4 Import Data For Ultrasound (Volume), By Country, 2017-2019 (Kilograms)
5.11 Technology Analysis
5.12 Average Selling Price Trend

6 Fetal Monitoring Market, By Product
6.1 Introduction
6.2 Ultrasound Devices
6.2.1 2D Ultrasound
6.2.1.1 The Increasing Commercialization Of Innovative 2D Technologies Drives The Growth Of This Segment
6.2.2 3D & 4D Ultrasound
6.2.2.1 Technological Advantages Of 3D & 4D Ultrasound Over 2D Ultrasound To Drive Segment Growth
6.2.3 Doppler Imaging
6.2.3.1 Doppler Imaging Analyzes Fetal Hemodynamics Useful For Fetal Surveillance; Key Factor Driving Segment Growth
6.3 Electronic Maternal/Fetal Monitors
6.3.1 The Rising Number Of High-Risk Pregnancies And The Requirement Of Advanced Fetal Monitoring Devices To Accelerate Segment Growth
6.4 Fetal Electrodes
6.4.1 The Need For Intrapartum Fetal Surveillance To Support The Market Growth Of This Segment
6.5 Fetal Doppler Devices
6.5.1 The Use Of Fetal Dopplers In-Home Care Settings To Drive Segment Growth
6.6 Uterine Contraction Monitors
6.6.1 Internal Uterine Contraction Monitors
6.6.1.1 The Accurate Measurement Obtained By Internal Ucms To Propel Segment Growth
6.6.2 External Uterine Contraction Monitors
6.6.2.1 The Noninvasive Nature Of External UCMS Is A Factor Supporting Market Growth
6.7 Telemetry Devices
6.7.1 The Benefit Of Remote Monitoring Incorporated Into Telemetry Devices Is A Major Factor Driving Market Growth
6.8 Accessories And Consumables
6.8.1 Advancements In Fetal Monitoring To Lead To The Increasing Utilization Of Accessories And Consumables
6.9 Other Products

7 Fetal Monitoring Market, By Portability
7.1 Introduction
7.2 Non-Portable Systems
7.2.1 Technological Advancements Of Non-Portable Systems To Support Market Growth
7.3 Portable Systems
7.3.1 Remote Accuracy Offered By Portable Systems Drives The Market Growth Of This Segment

8 Fetal Monitoring Market, By Method
8.1 Introduction
8.2 Noninvasive Method
8.2.1 Noninvasive Methods Are Widely Adopted In High-Risk Pregnancies, Thus Driving Market Growth
8.3 Invasive Method
8.3.1 Consistent Transmission Of The Fetal Heart Rate Via Invasive Methods Supports Market Growth

9 Fetal Monitoring Market, By Application
9.1 Introduction
9.2 Antepartum
9.2.1 Increasing Incidences Of Pregnancy-Related Complications To Support Growth Of This Segment
9.3 Intrapartum
9.3.1 Favourable Guidelines By Healthcare Authorities To Propel Growth Of The Segment

10 Fetal Monitoring Market, By End User
10.1 Introduction
10.2 Hospitals
10.2.1 The Availability Of Well-Established Healthcare Infrastructure Drives Segment Growth
10.3 Obstetrics & Gynecology Clinics
10.3.1 The Rising Emphasis On Perinatal Care To Bolster The Growth Of This Segment
10.4 Home Care Settings
10.4.1 Remote-Based Care By Portable Fetal Monitoring Systems Drives The Growth Of This End-User Segment

11 Fetal Monitoring Market, By Region
11.1 Introduction
11.2 North America
11.3 Europe
11.4 Asia Pacific
11.5 Rest Of The World

12 Competitive Landscape
12.1 Overview
12.2 Key Player Strategies
12.3 Market Share Analysis
12.4 Competitive Evaluation Matrix
12.4.1 Stars
12.4.2 Emerging Leaders
12.4.3 Pervasive
12.4.4 Participants
12.5 Competitive Leadership Mapping (Start-Ups And Smes)
12.5.1 Progressive Companies
12.5.2 Starting Blocks
12.5.3 Responsive Companies
12.5.4 Dynamic Companies
12.6 Company Product Footprint
12.7 Company Geographic Footprint Of Major Players In The Fetal Monitoring Market
12.8 Competitive Scenario

13 Company Profiles
13.1 Key Players
13.1.1 GE Healthcare
13.1.2 Siemens Healthineers
13.1.3 Cardinal Health, Inc.
13.1.4 Koninklijke Philips N.V.
13.1.5 Fujifilm Sonosite, Inc.
13.1.6 Huntleigh Healthcare Limited
13.1.7 Natus Medical Incorporated
13.1.8 The Cooper Companies Inc.
13.1.9 Contec Medical Systems Co., Ltd
13.1.10 Edan Diagnostics, Inc.
13.2 Other Players
13.2.1 Neoventa Medical Ab
13.2.2 Bionet Co., Ltd
13.2.3 Progetti Srl
13.2.4 Trismed Co., Ltd.
13.2.5 Shenzhen Luckcome Technology Inc.
13.2.6 Medgyn Products, Inc.
13.2.7 Dixion
13.2.8 Promed Group Co., Ltd.
13.2.9 Advanced Instrumentations
13.2.10 Brael-Medical Equipment
13.2.11 GPC Medical Ltd.
13.2.12 Monarch Meditech
13.2.13 Bistos Co., Ltd.
13.2.14 Mediana Co., Ltd
13.2.15 Life Plus Medical
13.2.16 Choicemmed
13.2.17 Trivitron Healthcare
13.2.18 Dott Medical Co. Ltd
13.2.19 Shenzhen Comen Medical Instruments Co., Ltd.

14 Appendix
14.1 Industry Insights
14.2 Discussion Guide
14.3 Knowledge Store
14.4 Available Customizations
14.5 Related Reports
14.6 Author Details

For more information about this report visit https://www.researchandmarkets.com/r/d7w0v4

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900